ArriVent Share Price

ArriVent Share Price

NASDAQ: AVBP | Small Cap | Healthcare
$10.56
-$0.68 (-6.05%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

ArriVent Stock Performance

Open
$10.89
Prev. Close
$11.24
Circuit Range
N/A
Day Range
$10.39 - $11.27
Year Range
$10.39 - $35.59
Volume
67,709
Average Traded
$10.74

ArriVent Share Price Today

As of 21 November 2026, ArriVent BioPharma, Inc.'s share price is $10.56. The stock opened at $10.89, compared to its previous close of $11.24. During today's trading session, ArriVent BioPharma, Inc.'s share price traded between $10.39 and $11.27, with an average price of $10.83. Over the past 52 weeks, the stock has recorded a high of $35.59 and a low of $10.39. In terms of performance, ArriVent BioPharma, Inc.'s share price has declined by 65.07% over the last six months and is down 53.97% on a year-on-year basis.

ArriVent Share Price Chart

Line chart of the ArriVent price trend over the selected period. The price fell overall, ranging from 10.39 to 11.30, ending at 10.50.
$10.39$11.27
L
Show Current Price
H

ArriVent Stock Fundamentals & Key Indicators

Market Cap
$406.17M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.27
Revenue (TTM)
$0.00
Return On Equity (TTM)
-42.97%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-13.42%

ArriVent Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$5.00
Net Profit-$35.54-$43.32-$49.89-$40.31
Net Profit MarginN/AN/AN/A-806.20%
Income ChangeN/A-21.89%-15.17%19.20%

ArriVent Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$80.49-$166.31
Net Profit MarginN/AN/A
Income ChangeN/A-106.62%

ArriVent Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets0.2747.96
Current Assets332.9226.98
Total Assets333.17274.94
Non Current Liabilities0.00.01
Current Liabilities25.9517.27
Total Liabilities25.9517.29
Shareholders' Equity307.22257.65

ArriVent Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-160.59-70.21
Investing-71.23-192.47
Financing203.06186.58

About ArriVent

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.

ArriVent Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$14.80
$10.49
-29.88%
Oct 2026
$30.49
$14.96
-50.72%
Sep 2026
$30.19
$30.36
-2.46%
Aug 2026
$30.58
$31.12
+4.31%
Jul 2026
$34.92
$29.84
-14.09%
Jun 2026
$29.61
$34.73
+14.89%
May 2026
$30.96
$30.23
-2.80%
Apr 2026
$23.41
$31.10
+34.63%
Mar 2026
$22.79
$23.10
+0.20%
Feb 2026
$22.10
$23.05
+2.49%
Jan 2026
$20.47
$22.50
+11.75%
Dec 2025
$22.09
$20.13
-12.25%

ArriVent Share Price FAQs